UR-1505

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUR-1505
Drug Alias NameUR-1505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLymphocytes inhibitorsCytokines inhibitorsNuclear factor of activated T-cells cytoplasmic 1 inhibitors
TargetsNuclear factor of activated T-cells cytoplasmic 1Cytokines
Therapy Area/IndicationsPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPalau PharmaUriach
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUriachPalau Pharma
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A